Suven Life Sciences Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
200.45 | 59.31 | 237.95% | 0.0929 | +215 669.12% |
| P/S |
|
136.26 | 8.65 | 1475.75% |
|
|
| P/BV |
|
5.9 | 6.53 | -9.66% |
|
|
| P/FCF |
|
-16.8 | 0.6184 | -2817.55% |
|
|
| Ev/Ebitda |
|
-11.17 | 141.49 | -107.9% |
|
|
| Ev/S |
|
122.3 | 8.63 | 1316.9% |
|
|
| Ev/FCF |
|
-17.28 | 9.08 | -290.24% |
|
|
| E/P |
|
-0.0755 | 0.1367 | -155.21% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1094.72 | 0.3647 | -300249.58% | -846.08 | +29.39% |
| ROE |
|
-38.91 | 7.22 | -638.78% |
|
|
| ROA |
|
-36.88 | 6.7 | -650.76% |
|
|
| ROIC |
|
0 | 15.91 | -100% |
|
|
| ROS |
|
-898.63 | -4.66 | 19164.15% |
|
|
| ROCE |
|
-49.81 | 11.71 | -525.38% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0055 | 123.39 | -100% | -0.0219 | -74.68% |
| Nеt Debt/Ebitda |
|
1.28 | 121.88 | -98.95% |
|
|
| Debt/Ratio |
|
0.0025 | 0.1698 | -98.53% |
|
|
| Debt/Equity |
|
0.0192 | 3.45 | -99.44% |
|
|
| Debt/Net Income |
|
-0.0068 | 3.06 | -100.22% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 9.62 | -100% | 0.4703 | -100% |
| Number of years of dividend growth |
|
0 | 0.7073 | -100% | ||
| DSI |
|
0.8571 | 0.8351 | 2.64% |
|
|
| Average dividend growth |
|
21.67 | -2.19 | -1087.89% |
|
|
| Average percentage for 5 years |
|
0.4703 | 14.83 | -96.83% |
|
|
| Average percentage for payments |
|
35.17 | 24.67 | 42.56% |
|
|
| Difference from average difference in sector |
|
-9.62 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-18.88 | 695.45 | -102.71% | ||
| Growth impulse Ebitda in 5 years |
|
25.19 | 617.6 | -95.92% | ||
| Growth impulse Net Income in 5 years |
|
11.52 | 759.48 | -98.48% | ||
| Growth impulse FCF in 5 years |
|
-57.82 | 1011.9 | -105.71% | ||
| Growth impulse EPS in 5 years |
|
557.47 | 220.4 | 152.94% |
IP Score
3.77/10
